Ticker Details
Alumis Inc. Common Stock
IPO Date:	June 28, 2024
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$3.86B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.51 | 4.77%
Avg Daily Range (30 D):	$0.84 | 3.62%
Avg Daily Range (90 D):	$0.86 | 3.54%

Institutional Daily Volume
Avg Daily Volume:	.86M
Avg Daily Volume (30 D):	1.27M
Avg Daily Volume (90 D):	1.16M

Trade Size
Avg Trade Size (Sh.):	82
Avg Trade Size (Sh.) (30 D):	61
Avg Trade Size (Sh.) (90 D):	60

Institutional Trades
Total Institutional Trades:	472
Avg Institutional Trade:	$2.25M
Avg Institutional Trade (30 D):	$3.87M
Avg Institutional Trade (90 D):	$2.99M
Avg Institutional Trade Volume:	.11M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$4.13M
Avg Closing Trade (30 D):	$7.65M
Avg Closing Trade (90 D):	$5.37M
Avg Closing Volume:	200.88K

News

May 17, 2026 @ 6:13 PM Alumis Stock Has Soared 400%. Cormorant Bought Ano... Source: Jonathan Ponciano

Apr 14, 2026 @ 5:00 PM The Psoriasis Clinical Trial Pipeline Boom as 90+ ... Source: Delveinsight

Mar 28, 2026 @ 5:30 PM Alumis’ Envudeucitinib Delivers Early and R... Source: Na

Jan 8, 2026 @ 3:52 AM Alumis Announces Pricing of Upsized Public Offerin... Source: Na

Jan 6, 2026 @ 10:12 PM Stock Market Today, Jan. 6: Alumis Shares Surge on... Source: Howard Smith

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-1.78	$-.74	$-.94
Diluted EPS	$-1.78	$-.74	$-.94
Revenue	$8.4M	$1.74M	$1.93M
Gross Profit
Net Income / Loss	$-237.42M	$-93.05M	$-92.93M
Operating Income / Loss	$-450.69M	$-98.41M	$-96.45M
Cost of Revenue
Net Cash Flow	$-105.36M	$-25.78M	$24.42M
PE Ratio